不安障害とうつ病治療の市場規模、シェア、動向分析レポート：薬物タイプ別、適応症別、流通チャネル別、地域別、セグメント別予測、2025年～2030年

不安障害とうつ病治療市場の成長と動向

Grand View Research, Inc.の最新レポートによると、世界の不安障害・うつ病治療市場規模は2030年までに192億8,000万米ドルに達すると推定され、2025～2030年にかけて3.8%のCAGRで成長する見込みです。

世界のうつ病罹患率の上昇が、今後数年間の市場成長を促進すると予測されています。機器や心理療法の採用が増加しているため、近年は抗うつ薬の需要が減少しています。

うつ病になりやすい高齢者の増加や、恐怖症や全般性不安障害などの不安障害の急増が、予測期間中に精神疾患を治療するための抗うつ薬の需要拡大にさらに寄与しています。さらに、脳刺激に使用される医療用インプラントやスマートフォンベースのアプリケーションを使用したバーチャルリアリティ暴露療法などの技術的に先進的治療法の導入は、患者に革新的な治療選択肢を提供しています。

不安障害とうつ病治療市場レポートハイライト

• 抗うつ薬セグメントが市場を独占し、2024年には32.4%の最高収益シェアを占めました。
• 不安症は、2024年に55.4%の収益シェアを占め、市場をリードしました。これは、既成経済圏と成長経済圏の両方で、恐怖症、社会不安障害、その他の類似疾患が増加していることが要因です。
• 小売薬局セグメントは、患者が近くて信頼できる薬局を好むため、2024年に55.4％の最大市場シェアを占めました。
• 北米の不安障害とうつ病治療市場は、2024年に37.6％の収益シェアで世界市場を独占しました。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 不安障害とうつ病治療市場の変数、動向、範囲

• 市場系統の展望
• 市場力学
  • 市場促進要因分析
  • 市場抑制要因分析
• ビジネス環境分析
  • 産業分析-ポーターのファイブフォース分析
  • PESTLE分析
  • パイプライン分析

第4章 不安障害とうつ病治療市場：薬物タイプ別ビジネス分析

• 薬物タイプ別市場シェア、2024年と2030年
• 薬物タイプセグメントダッシュボード
• 市場規模と予測と動向分析、薬物タイプ別、2018～2030年
• 抗うつ薬
• 抗不安薬
• 抗けいれん薬
• ノルアドレナリン作動薬
• 非定型抗精神病薬

第5章 不安障害とうつ病治療市場：適応症ビジネス分析

• 適応症市場シェア、2024年と2030年
• 適応症セグメントダッシュボード
• 市場規模と予測と動向分析、適応症別、2018～2030年
• うつ病
• 不安障害

第6章 不安障害とうつ病治療市場：流通チャネルビジネス分析

• 流通チャネル市場シェア、2024年と2030年
• 流通チャネルセグメントダッシュボード
• 市場規模と予測と動向分析、流通チャネル別、2018～2030年
• 病院薬局
• 小売薬局
• その他

第7章 不安障害とうつ病治療市場：地域別、推定・動向分析

• 地域別市場シェア分析、2024年と2030年
• 地域別市場ダッシュボード
• 市場規模、予測動向分析、2018～2030年
• 北米
  • 国別、2018～2030年
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • 国別、2018～2030年
  • 英国
  • ドイツ
  • フランス
  • イタリア
  • スペイン
  • ノルウェー
  • デンマーク
  • スウェーデン
• アジア太平洋
  • 国別、2018～2030年
  • 日本
  • 中国
  • インド
  • 韓国
  • オーストラリア
  • タイ
• ラテンアメリカ
  • 国別、2018～2030年
  • ブラジル
  • アルゼンチン
• 中東・アフリカ
  • 国別、2018～2030年
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • クウェート

第8章 競合情勢

• 参加者概要
• 企業の市況分析
• 企業分類
• 戦略マッピング
• 企業プロファイル/上場企業
  • Pfizer Inc.
  • H. Lundbeck A/S
  • GSK plc
  • Merck & Co., Inc.
  • Eli Lilly and Company
  • AstraZeneca
  • Bristol-Myers Squibb Company
  • Johnson & Johnson Services, Inc.
  • AbbVie Inc.
  • Sanofi

List of Tables

• Table 1. List of secondary sources
• Table 2. List of abbreviations
• Table 3. Global anxiety disorders and depression treatment market, by region, 2018 - 2030 (USD Million)
• Table 4. Global anxiety disorders and depression treatment market, by drug type, 2018 - 2030 (USD Million)
• Table 5. Global anxiety disorders and depression treatment market, by indication, 2018 - 2030 (USD Million)
• Table 6. Global anxiety disorders and depression treatment market, by distribution channel, 2018 - 2030 (USD Million)
• Table 7. North America anxiety disorders and depression treatment market, by country, 2018 - 2030 (USD Million)
• Table 8. North America anxiety disorders and depression treatment market, by drug type, 2018 - 2030 (USD Million)
• Table 9. North America anxiety disorders and depression treatment market, by indication, 2018 - 2030 (USD Million)
• Table 10. North America anxiety disorders and depression treatment market, by distribution channel, 2018 - 2030 (USD Million)
• Table 11. U.S. anxiety disorders and depression treatment market, by drug type, 2018 - 2030 (USD Million)
• Table 12. U.S. anxiety disorders and depression treatment market, by indication, 2018 - 2030 (USD Million)
• Table 13. U.S. Anxiety disorders and depression treatment market, by distribution channel, 2018 - 2030 (USD Million)
• Table 14. Canada anxiety disorders and depression treatment market, by drug type, 2018 - 2030 (USD Million)
• Table 15. Canada anxiety disorders and depression treatment market, by indication, 2018 - 2030 (USD Million)
• Table 16. Canada anxiety disorders and depression treatment market, by distribution channel, 2018 - 2030 (USD Million)
• Table 17. Mexico anxiety disorders and depression treatment market, by drug type, 2018 - 2030 (USD Million)
• Table 18. Mexico anxiety disorders and depression treatment market, by indication, 2018 - 2030 (USD Million)
• Table 19. Mexico anxiety disorders and depression treatment market, by distribution channel, 2018 - 2030 (USD Million)
• Table 20. Europe anxiety disorders and depression treatment market, by country, 2018 - 2030 (USD Million)
• Table 21. Europe anxiety disorders and depression treatment market, by drug type, 2018 - 2030 (USD Million)
• Table 22. Europe anxiety disorders and depression treatment market, by indication, 2018 - 2030 (USD Million)
• Table 23. Europe anxiety disorders and depression treatment market, by distribution channel, 2018 - 2030 (USD Million)
• Table 24. UK anxiety disorders and depression treatment market, by drug type, 2018 - 2030 (USD Million)
• Table 25. UK anxiety disorders and depression treatment market, by indication, 2018 - 2030 (USD Million)
• Table 26. UK Anxiety disorders and depression treatment market, by distribution channel, 2018 - 2030 (USD Million)
• Table 27. Germany anxiety disorders and depression treatment market, by drug type, 2018 - 2030 (USD Million)
• Table 28. Germany anxiety disorders and depression treatment market, by indication, 2018 - 2030 (USD Million)
• Table 29. Germany anxiety disorders and depression treatment market, by distribution channel, 2018 - 2030 (USD Million)
• Table 30. France anxiety disorders and depression treatment market, by drug type, 2018 - 2030 (USD Million)
• Table 31. France anxiety disorders and depression treatment market, by indication, 2018 - 2030 (USD Million)
• Table 32. France Anxiety disorders and depression treatment market, by distribution channel, 2018 - 2030 (USD Million)
• Table 33. Italy anxiety disorders and depression treatment market, by drug type, 2018 - 2030 (USD Million)
• Table 34. Italy anxiety disorders and depression treatment market, by indication, 2018 - 2030 (USD Million)
• Table 35. Italy anxiety disorders and depression treatment market, by distribution channel, 2018 - 2030 (USD Million)
• Table 36. Spain anxiety disorders and depression treatment market, by drug type, 2018 - 2030 (USD Million)
• Table 37. Spain anxiety disorders and depression treatment market, by indication, 2018 - 2030 (USD Million)
• Table 38. Spain anxiety disorders and depression treatment market, by distribution channel, 2018 - 2030 (USD Million)
• Table 39. Norway anxiety disorders and depression treatment market, by drug type, 2018 - 2030 (USD Million)
• Table 40. Norway anxiety disorders and depression treatment market, by indication, 2018 - 2030 (USD Million)
• Table 41. Norway Anxiety disorders and depression treatment market, by distribution channel, 2018 - 2030 (USD Million)
• Table 42. Denmark anxiety disorders and depression treatment market, by drug type, 2018 - 2030 (USD Million)
• Table 43. Denmark anxiety disorders and depression treatment market, by indication, 2018 - 2030 (USD Million)
• Table 44. Denmark anxiety disorders and depression treatment market, by distribution channel, 2018 - 2030 (USD Million)
• Table 45. Sweden anxiety disorders and depression treatment market, by drug type, 2018 - 2030 (USD Million)
• Table 46. Sweden anxiety disorders and depression treatment market, by indication, 2018 - 2030 (USD Million)
• Table 47. Sweden anxiety disorders and depression treatment market, by distribution channel, 2018 - 2030 (USD Million)
• Table 48. Asia Pacific anxiety disorders and depression treatment market, by country, 2018 - 2030 (USD Million)
• Table 49. Asia Pacific anxiety disorders and depression treatment market, by drug type, 2018 - 2030 (USD Million)
• Table 50. Asia Pacific anxiety disorders and depression treatment market, by indication, 2018 - 2030 (USD Million)
• Table 51. Asia Pacific anxiety disorders and depression treatment market, by distribution channel, 2018 - 2030 (USD Million)
• Table 52. Japan anxiety disorders and depression treatment market, by drug type, 2018 - 2030 (USD Million)
• Table 53. Japan anxiety disorders and depression treatment market, by indication, 2018 - 2030 (USD Million)
• Table 54. Japan anxiety disorders and depression treatment market, by distribution channel, 2018 - 2030 (USD Million)
• Table 55. China anxiety disorders and depression treatment market, by drug type, 2018 - 2030 (USD Million)
• Table 56. China anxiety disorders and depression treatment market, by indication, 2018 - 2030 (USD Million)
• Table 57. China anxiety disorders and depression treatment market, by distribution channel, 2018 - 2030 (USD Million)
• Table 58. India anxiety disorders and depression treatment market, by drug type, 2018 - 2030 (USD Million)
• Table 59. India anxiety disorders and depression treatment market, by indication, 2018 - 2030 (USD Million)
• Table 60. India anxiety disorders and depression treatment market, by distribution channel, 2018 - 2030 (USD Million)
• Table 61. Australia anxiety disorders and depression treatment market, by drug type, 2018 - 2030 (USD Million)
• Table 62. Australia anxiety disorders and depression treatment market, by indication, 2018 - 2030 (USD Million)
• Table 63. Australia anxiety disorders and depression treatment market, by distribution channel, 2018 - 2030 (USD Million)
• Table 64. South Korea anxiety disorders and depression treatment market, by drug type, 2018 - 2030 (USD Million)
• Table 65. South Korea anxiety disorders and depression treatment market, by indication, 2018 - 2030 (USD Million)
• Table 66. South Korea anxiety disorders and depression treatment market, by distribution channel, 2018 - 2030 (USD Million)
• Table 67. Thailand anxiety disorders and depression treatment market, by drug type, 2018 - 2030 (USD Million)
• Table 68. Thailand anxiety disorders and depression treatment market, by indication, 2018 - 2030 (USD Million)
• Table 69. Thailand anxiety disorders and depression treatment market, by distribution channel, 2018 - 2030 (USD Million)
• Table 70. Latin America anxiety disorders and depression treatment market, by country, 2018 - 2030 (USD Million)
• Table 71. Latin America anxiety disorders and depression treatment market, by drug type, 2018 - 2030 (USD Million)
• Table 72. Latin America anxiety disorders and depression treatment market, by indication, 2018 - 2030 (USD Million)
• Table 73. Latin America anxiety disorders and depression treatment market, by distribution channel, 2018 - 2030 (USD Million)
• Table 74. Brazil anxiety disorders and depression treatment market, by drug type, 2018 - 2030 (USD Million)
• Table 75. Brazil anxiety disorders and depression treatment market, by indication, 2018 - 2030 (USD Million)
• Table 76. Brazil anxiety disorders and depression treatment market, by distribution channel, 2018 - 2030 (USD Million)
• Table 77. Argentina anxiety disorders and depression treatment market, by drug type, 2018 - 2030 (USD Million)
• Table 78. Argentina anxiety disorders and depression treatment market, by indication, 2018 - 2030 (USD Million)
• Table 79. Argentina anxiety disorders and depression treatment market, by distribution channel, 2018 - 2030 (USD Million)
• Table 80. Middle East & Africa Anxiety disorders and depression treatment market, by country, 2018 - 2030 (USD Million)
• Table 81. Middle East & Africa anxiety disorders and depression treatment market, by drug type, 2018 - 2030 (USD Million)
• Table 82. Middle East & Africa anxiety disorders and depression treatment market, by indication, 2018 - 2030 (USD Million)
• Table 83. Middle East & Africa anxiety disorders and depression treatment market, by distribution channel, 2018 - 2030 (USD Million)
• Table 84. South Africa anxiety disorders and depression treatment market, by drug type, 2018 - 2030 (USD Million)
• Table 85. South Africa anxiety disorders and depression treatment market, by indication, 2018 - 2030 (USD Million)
• Table 86. South Africa anxiety disorders and depression treatment market, by distribution channel, 2018 - 2030 (USD Million)
• Table 87. Saudi Arabia anxiety disorders and depression treatment market, by drug type, 2018 - 2030 (USD Million)
• Table 88. Saudi Arabia anxiety disorders and depression treatment market, by indication, 2018 - 2030 (USD Million)
• Table 89. Saudi Arabia anxiety disorders and depression treatment market, by distribution channel, 2018 - 2030 (USD Million)
• Table 90. UAE anxiety disorders and depression treatment market, by drug type, 2018 - 2030 (USD Million)
• Table 91. UAE anxiety disorders and depression treatment market, by indication, 2018 - 2030 (USD Million)
• Table 92. UAE anxiety disorders and depression treatment market, by distribution channel, 2018 - 2030 (USD Million)
• Table 93. Kuwait anxiety disorders and depression treatment market, by drug type, 2018 - 2030 (USD Million)
• Table 94. Kuwait anxiety disorders and depression treatment market, by indication, 2018 - 2030 (USD Million)
• Table 95. Kuwait anxiety disorders and depression treatment market, by distribution channel, 2018 - 2030 (USD Million)

List of Figures

• Fig. 1 Anxiety disorders and depression treatment market segmentation
• Fig. 2 Market research process
• Fig. 3 Data triangulation techniques
• Fig. 4 Primary research pattern
• Fig. 5 Market research approaches
• Fig. 6 Value-chain-based sizing & forecasting
• Fig. 7 Market formulation & validation
• Fig. 8 Market snapshot
• Fig. 9 Drug type and indication outlook (USD Million)
• Fig. 10 Distribution channel outlook (USD Million)
• Fig. 11 Competitive landscape
• Fig. 12 Anxiety disorders and depression treatment market dynamics
• Fig. 13 Anxiety disorders and depression treatment market: Porter's five forces analysis
• Fig. 14 Anxiety disorders and depression treatment market: PESTLE analysis
• Fig. 15 Anxiety disorders and depression treatment market: Drug type segment dashboard
• Fig. 16 Anxiety disorders and depression treatment market: Drug type market share analysis, 2024 & 2030
• Fig. 17 Antidepressants market, 2018 - 2030 (USD Million)
• Fig. 18 Anxiolytics market, 2018 - 2030 (USD Million)
• Fig. 19 Anticonvulsants market, 2018 - 2030 (USD Million)
• Fig. 20 Noradrenergic agents market, 2018 - 2030 (USD Million)
• Fig. 21 Atypical antipsychotics market, 2018 - 2030 (USD Million)
• Fig. 22 Anxiety disorders and depression treatment market: Indication segment dashboard
• Fig. 23 Anxiety disorders and depression treatment market: Indication market share analysis, 2024 & 2030
• Fig. 24 Depression market, 2018 - 2030 (USD Million)
• Fig. 25 Anxiety market, 2018 - 2030 (USD Million)
• Fig. 26 Anxiety disorders and depression treatment market: Distribution channel segment dashboard
• Fig. 27 Anxiety disorders and depression treatment market: Distribution channel market share analysis, 2024 & 2030
• Fig. 28 Hospital pharmacies market, 2018 - 2030 (USD Million)
• Fig. 29 Retail pharmacies market, 2018 - 2030 (USD Million)
• Fig. 30 Others market, 2018 - 2030 (USD Million)
• Fig. 31 Anxiety disorders and depression treatment market revenue, by region
• Fig. 32 Regional marketplace: Key takeaways
• Fig. 33 Regional marketplace: Key takeaways
• Fig. 34 North America anxiety disorders and depression treatment market, 2018 - 2030 (USD Million)
• Fig. 35 U.S. country dynamics
• Fig. 36 U.S. anxiety disorders and depression treatment market, 2018 - 2030 (USD Million)
• Fig. 37 Canada country dynamics
• Fig. 38 Canada anxiety disorders and depression treatment market, 2018 - 2030 (USD Million)
• Fig. 39 Mexico country dynamics
• Fig. 40 Mexico anxiety disorders and depression treatment market, 2018 - 2030 (USD Million)
• Fig. 41 Europe anxiety disorders and depression treatment market, 2018 - 2030 (USD Million)
• Fig. 42 UK country dynamics
• Fig. 43 UK anxiety disorders and depression treatment market, 2018 - 2030 (USD Million)
• Fig. 44 Germany country dynamics
• Fig. 45 Germany anxiety disorders and depression treatment market, 2018 - 2030 (USD Million)
• Fig. 46 France country dynamics
• Fig. 47 France anxiety disorders and depression treatment market, 2018 - 2030 (USD Million)
• Fig. 48 Italy country dynamics
• Fig. 49 Italy anxiety disorders and depression treatment market, 2018 - 2030 (USD Million)
• Fig. 50 Spain country dynamics
• Fig. 51 Spain anxiety disorders and depression treatment market, 2018 - 2030 (USD Million)
• Fig. 52 Norway country dynamics
• Fig. 53 Norway anxiety disorders and depression treatment market, 2018 - 2030 (USD Million)
• Fig. 54 Sweden country dynamics
• Fig. 55 Sweden anxiety disorders and depression treatment market, 2018 - 2030 (USD Million)
• Fig. 56 Denmark country dynamics
• Fig. 57 Denmark anxiety disorders and depression treatment market, 2018 - 2030 (USD Million)
• Fig. 58 Asia Pacific anxiety disorders and depression treatment market, 2018 - 2030 (USD Million)
• Fig. 59 Japan country dynamics
• Fig. 60 Japan anxiety disorders and depression treatment market, 2018 - 2030 (USD Million)
• Fig. 61 China country dynamics
• Fig. 62 China anxiety disorders and depression treatment market, 2018 - 2030 (USD Million)
• Fig. 63 India country dynamics
• Fig. 64 India anxiety disorders and depression treatment market, 2018 - 2030 (USD Million)
• Fig. 65 Australia country dynamics
• Fig. 66 Australia anxiety disorders and depression treatment market, 2018 - 2030 (USD Million)
• Fig. 67 South Korea country dynamics
• Fig. 68 South Korea anxiety disorders and depression treatment market, 2018 - 2030 (USD Million)
• Fig. 69 Thailand country dynamics
• Fig. 70 Thailand anxiety disorders and depression treatment market, 2018 - 2030 (USD Million)
• Fig. 71 Latin America anxiety disorders and depression treatment market, 2018 - 2030 (USD Million)
• Fig. 72 Brazil country dynamics
• Fig. 73 Brazil anxiety disorders and depression treatment market, 2018 - 2030 (USD Million)
• Fig. 74 Argentina country dynamics
• Fig. 75 Argentina anxiety disorders and depression treatment market, 2018 - 2030 (USD Million)
• Fig. 76 MEA anxiety disorders and depression treatment market, 2018 - 2030 (USD Million)
• Fig. 77 South Africa country dynamics
• Fig. 78 South Africa anxiety disorders and depression treatment market, 2018 - 2030 (USD Million)
• Fig. 79 Saudi Arabia country dynamics
• Fig. 80 Saudi Arabia anxiety disorders and depression treatment market, 2018 - 2030 (USD Million)
• Fig. 81 UAE country dynamics
• Fig. 82 UAE anxiety disorders and depression treatment market, 2018 - 2030 (USD Million)
• Fig. 83 Kuwait country dynamics
• Fig. 84 Kuwait anxiety disorders and depression treatment market, 2018 - 2030 (USD Million)
• Fig. 85 Company categorization
• Fig. 86 Company market position analysis
• Fig. 87 Strategic framework

Anxiety Disorders And Depression Treatment Market Growth & Trends:

The global anxiety disorders and depression treatment market size is estimated to reach USD 19.28 billion by 2030, registering to grow at a CAGR of 3.8% from 2025 to 2030 according to a new report by Grand View Research, Inc. The rising incidence of depression worldwide is anticipated to drive the market growth in the coming years. Increasing adoption of devices and psychotherapies has resulted in the declining demand for antidepressants in recent years.

The rising geriatric population prone to depression and surging prevalence of anxiety disorders, including phobias and generalized anxiety disorder, are further contributing toward the growing demand for antidepressants to treat mental illnesses over the forecast period. Moreover, the introduction of technologically advanced therapies, such as medical implants used for brain stimulation and virtual reality exposure therapies using smartphone-based applications, furnish patients with innovative treatment alternatives.

Anxiety Disorders And Depression Treatment Market Report Highlights:

• The antidepressants segment dominated the market and accounted for the highest revenue share of 32.4% in 2024.
• Anxiety led the market with a revenue share of 55.4% in 2024, fueled by the increased presence of phobias, social anxiety disorders, and other similar conditions in both established and growing economies.
• The retail pharmacies segment held the largest market share of 55.4% in 2024 due to patients' preference for nearby, trustworthy pharmacies.
• North America anxiety disorders and depression treatment market dominated the global market with a revenue share of 37.6% in 2024.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Drug Type
  • 1.2.2. Indication
  • 1.2.3. Distribution Channel
• 1.3. Estimates and Forecast Timeline
• 1.4. Research Methodology
• 1.5. Information Procurement
  • 1.5.1. Purchased Database
  • 1.5.2. GVR's Internal Database
  • 1.5.3. Secondary Sources
  • 1.5.4. Primary Research
• 1.6. Information Analysis
  • 1.6.1. Data Analysis Models
• 1.7. Market Formulation & Data Visualization
• 1.8. Model Details
  • 1.8.1. Commodity Flow Analysis
• 1.9. List of Secondary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Snapshot
• 2.2. Segment Snapshot
• 2.3. Competitive Landscape Snapshot

Chapter 3. Anxiety Disorders and Depression Treatment Market Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
  • 3.2.2. Market Restraint Analysis
• 3.3. Business Environment Analysis
  • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
    • 3.3.1.1. Supplier Power
    • 3.3.1.2. Buyer Power
    • 3.3.1.3. Substitution Threat
    • 3.3.1.4. Threat of New Entrants
    • 3.3.1.5. Competitive Rivalry
  • 3.3.2. PESTLE Analysis
  • 3.3.3. Pipeline Analysis

Chapter 4. Anxiety Disorders and Depression Treatment Market: Drug Type Business Analysis

• 4.1. Drug Type Market Share, 2024 & 2030
• 4.2. Drug Type Segment Dashboard
• 4.3. Market Size & Forecasts and Trend Analysis, by Drug Type, 2018 to 2030 (USD Million)
• 4.4. Antidepressants
  • 4.4.1. Antidepressants Market, 2018 - 2030 (USD Million)
• 4.5. Anxiolytics
  • 4.5.1. Anxiolytics Market, 2018 - 2030 (USD Million)
• 4.6. Anticonvulsants
  • 4.6.1. Anticonvulsants Market, 2018 - 2030 (USD Million)
• 4.7. Noradrenergic Agents
  • 4.7.1. Noradrenergic Agents Market, 2018 - 2030 (USD Million)
• 4.8. Atypical Antipsychotics
  • 4.8.1. Atypical Antipsychotics Market, 2018 - 2030 (USD Million)

Chapter 5. Anxiety Disorders and Depression Treatment Market: Indication Business Analysis

• 5.1. Indication Market Share, 2024 & 2030
• 5.2. Indication Segment Dashboard
• 5.3. Market Size & Forecasts and Trend Analysis, by Indication, 2018 to 2030 (USD Million)
• 5.4. Depression
  • 5.4.1. Depression Market, 2018 - 2030 (USD Million)
• 5.5. Anxiety
  • 5.5.1. Anxiety Market, 2018 - 2030 (USD Million)

Chapter 6. Anxiety Disorders and Depression Treatment Market: Distribution Channel Business Analysis

• 6.1. Distribution Channel Market Share, 2024 & 2030
• 6.2. Distribution Channel Segment Dashboard
• 6.3. Market Size & Forecasts and Trend Analysis, by Distribution Channel, 2018 to 2030 (USD Million)
• 6.4. Hospital Pharmacies
  • 6.4.1. Hospital Pharmacies Market, 2018 - 2030 (USD Million)
• 6.5. Retail Pharmacies
  • 6.5.1. Retail Pharmacies Market, 2018 - 2030 (USD Million)
• 6.6. Others
  • 6.6.1. Others Market, 2018 - 2030 (USD Million)

Chapter 7. Anxiety Disorders and Depression Treatment Market: Regional Estimates & Trend Analysis

• 7.1. Regional Market Share Analysis, 2024 & 2030
• 7.2. Regional Market Dashboard
• 7.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
• 7.4. North America
  • 7.4.1. North America Anxiety Disorders and Depression Treatment Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
  • 7.4.2. U.S.
    • 7.4.2.1. Key Country Dynamics
    • 7.4.2.2. Regulatory Framework
    • 7.4.2.3. Competitive Insights
    • 7.4.2.4. U.S. Anxiety Disorders and Depression Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.4.3. Canada
    • 7.4.3.1. Key Country Dynamics
    • 7.4.3.2. Regulatory Framework
    • 7.4.3.3. Competitive Insights
    • 7.4.3.4. Canada Anxiety Disorders and Depression Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.4.4. Mexico
    • 7.4.4.1. Key Country Dynamics
    • 7.4.4.2. Regulatory Framework
    • 7.4.4.3. Competitive Insights
    • 7.4.4.4. Mexico Anxiety Disorders and Depression Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• 7.5. Europe
  • 7.5.1. Europe Anxiety Disorders and Depression Treatment Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
  • 7.5.2. UK
    • 7.5.2.1. Key Country Dynamics
    • 7.5.2.2. Regulatory Framework
    • 7.5.2.3. Competitive Insights
    • 7.5.2.4. UK Anxiety Disorders and Depression Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.5.3. Germany
    • 7.5.3.1. Key Country Dynamics
    • 7.5.3.2. Regulatory Framework
    • 7.5.3.3. Competitive Insights
    • 7.5.3.4. Germany Anxiety Disorders and Depression Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.5.4. France
    • 7.5.4.1. Key Country Dynamics
    • 7.5.4.2. Regulatory Framework
    • 7.5.4.3. Competitive Insights
    • 7.5.4.4. France Anxiety Disorders and Depression Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.5.5. Italy
    • 7.5.5.1. Key Country Dynamics
    • 7.5.5.2. Regulatory Framework
    • 7.5.5.3. Competitive Insights
    • 7.5.5.4. Italy Anxiety Disorders and Depression Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.5.6. Spain
    • 7.5.6.1. Key Country Dynamics
    • 7.5.6.2. Regulatory Framework
    • 7.5.6.3. Competitive Insights
    • 7.5.6.4. Spain Anxiety Disorders and Depression Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.5.7. Norway
    • 7.5.7.1. Key Country Dynamics
    • 7.5.7.2. Regulatory Framework
    • 7.5.7.3. Competitive Insights
    • 7.5.7.4. Norway Anxiety Disorders and Depression Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.5.8. Denmark
    • 7.5.8.1. Key Country Dynamics
    • 7.5.8.2. Regulatory Framework
    • 7.5.8.3. Competitive Insights
    • 7.5.8.4. Denmark Anxiety Disorders and Depression Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.5.9. Sweden
    • 7.5.9.1. Key Country Dynamics
    • 7.5.9.2. Regulatory Framework
    • 7.5.9.3. Competitive Insights
    • 7.5.9.4. Sweden Anxiety Disorders and Depression Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• 7.6. Asia Pacific
  • 7.6.1. Asia Pacific Anxiety Disorders and Depression Treatment Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
  • 7.6.2. Japan
    • 7.6.2.1. Key Country Dynamics
    • 7.6.2.2. Regulatory Framework
    • 7.6.2.3. Competitive Insights
    • 7.6.2.4. Japan Anxiety Disorders and Depression Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.6.3. China
    • 7.6.3.1. Key Country Dynamics
    • 7.6.3.2. Regulatory Framework
    • 7.6.3.3. Competitive Insights
    • 7.6.3.4. China Anxiety Disorders and Depression Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.6.4. India
    • 7.6.4.1. Key Country Dynamics
    • 7.6.4.2. Regulatory Framework
    • 7.6.4.3. Competitive Insights
    • 7.6.4.4. India Anxiety Disorders and Depression Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.6.5. South Korea
    • 7.6.5.1. Key Country Dynamics
    • 7.6.5.2. Regulatory Framework
    • 7.6.5.3. Competitive Insights
    • 7.6.5.4. South Korea Anxiety Disorders and Depression Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.6.6. Australia
    • 7.6.6.1. Key Country Dynamics
    • 7.6.6.2. Regulatory Framework
    • 7.6.6.3. Competitive Insights
    • 7.6.6.4. Australia Anxiety Disorders and Depression Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.6.7. Thailand
    • 7.6.7.1. Key Country Dynamics
    • 7.6.7.2. Regulatory Framework
    • 7.6.7.3. Competitive Insights
    • 7.6.7.4. Thailand Anxiety Disorders and Depression Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• 7.7. Latin America
  • 7.7.1. Latin America Anxiety Disorders and Depression Treatment Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
  • 7.7.2. Brazil
    • 7.7.2.1. Key Country Dynamics
    • 7.7.2.2. Regulatory Framework
    • 7.7.2.3. Competitive Insights
    • 7.7.2.4. Brazil Anxiety Disorders and Depression Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.7.3. Argentina
    • 7.7.3.1. Key Country Dynamics
    • 7.7.3.2. Regulatory Framework
    • 7.7.3.3. Competitive Insights
    • 7.7.3.4. Argentina Anxiety Disorders and Depression Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• 7.8. MEA
  • 7.8.1. MEA Anxiety Disorders and Depression Treatment Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
  • 7.8.2. South Africa
    • 7.8.2.1. Key Country Dynamics
    • 7.8.2.2. Regulatory Framework
    • 7.8.2.3. Competitive Insights
    • 7.8.2.4. South Africa Anxiety Disorders and Depression Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.8.3. Saudi Arabia
    • 7.8.3.1. Key Country Dynamics
    • 7.8.3.2. Regulatory Framework
    • 7.8.3.3. Competitive Insights
    • 7.8.3.4. Saudi Arabia Anxiety Disorders and Depression Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.8.4. UAE
    • 7.8.4.1. Key Country Dynamics
    • 7.8.4.2. Regulatory Framework
    • 7.8.4.3. Competitive Insights
    • 7.8.4.4. UAE Anxiety Disorders and Depression Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.8.5. Kuwait
    • 7.8.5.1. Key Country Dynamics
    • 7.8.5.2. Regulatory Framework
    • 7.8.5.3. Competitive Insights
    • 7.8.5.4. Kuwait Anxiety Disorders and Depression Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

• 8.1. Participant Overview
• 8.2. Company Market Position Analysis
• 8.3. Company Categorization
• 8.4. Strategy Mapping
• 8.5. Company Profiles/Listing
  • 8.5.1. Pfizer Inc.
    • 8.5.1.1. Overview
    • 8.5.1.2. Financial Performance
    • 8.5.1.3. Product Benchmarking
    • 8.5.1.4. Strategic Initiatives
  • 8.5.2. H. Lundbeck A/S
    • 8.5.2.1. Overview
    • 8.5.2.2. Financial Performance
    • 8.5.2.3. Product Benchmarking
    • 8.5.2.4. Strategic Initiatives
  • 8.5.3. GSK plc
    • 8.5.3.1. Overview
    • 8.5.3.2. Financial Performance
    • 8.5.3.3. Product Benchmarking
    • 8.5.3.4. Strategic Initiatives
  • 8.5.4. Merck & Co., Inc.
    • 8.5.4.1. Overview
    • 8.5.4.2. Financial Performance
    • 8.5.4.3. Product Benchmarking
    • 8.5.4.4. Strategic Initiatives
  • 8.5.5. Eli Lilly and Company
    • 8.5.5.1. Overview
    • 8.5.5.2. Financial Performance
    • 8.5.5.3. Product Benchmarking
    • 8.5.5.4. Strategic Initiatives
  • 8.5.6. AstraZeneca
    • 8.5.6.1. Overview
    • 8.5.6.2. Financial Performance
    • 8.5.6.3. Product Benchmarking
    • 8.5.6.4. Strategic Initiatives
  • 8.5.7. Bristol-Myers Squibb Company
    • 8.5.7.1. Overview
    • 8.5.7.2. Financial Performance
    • 8.5.7.3. Product Benchmarking
    • 8.5.7.4. Strategic Initiatives
  • 8.5.8. Johnson & Johnson Services, Inc.
    • 8.5.8.1. Overview
    • 8.5.8.2. Financial Performance
    • 8.5.8.3. Product Benchmarking
    • 8.5.8.4. Strategic Initiatives
  • 8.5.9. AbbVie Inc.
    • 8.5.9.1. Overview
    • 8.5.9.2. Financial Performance
    • 8.5.9.3. Product Benchmarking
    • 8.5.9.4. Strategic Initiatives
  • 8.5.10. Sanofi
    • 8.5.10.1. Overview
    • 8.5.10.2. Financial Performance
    • 8.5.10.3. Product Benchmarking
    • 8.5.10.4. Strategic Initiatives